{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:16:11Z","timestamp":1787062571066,"version":"build-2736575974"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The relatively high incidence and the clinical symptoms of sex chromosome aneuploidies (SCAs) make prenatal screening of SCAs an attractive option for pregnant women. However, limited studies have assessed the clinical performance of noninvasive prenatal testing (NIPT) for screening SCAs. This study was performed to evaluate the clinical performance of NIPT for SCAs in singleton pregnancies in central China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Noninvasive prenatal testing was performed using next-generation sequencing. Standard Z-score analysis was used to identify fetal SCAs. NIPT-positive results were confirmed by invasive prenatal diagnosis (IPD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 42,164 pregnant women with singleton pregnancies were recruited in this study. They were divided into the following five groups with different clinical indications: with ultrasound soft index abnormalities (9.23%, 3,892\/42,164); with advanced maternal age (22.14%, 9,336\/42,164); with high risk for maternal serum screening (MSS) (18.35%, 7,738\/42,164); with an intermediate risk for MSS (26.6%, 11,215\/42,164); and with low risk (23.68%, 9,983\/42,164). In all, 223 women had a high risk for SCAs by NIPT with a positive rate of 0.53%. There was no significant difference associated with the five groups in the positive rate. Of all of the positive results, 89 were 45,X (39.91%), 38 were 47,XXX (17.04%), 31 were 46,XY,del(X) (13.90%), 50 were 47,XXY (22.42%,), and 15 were 47,XYY (6.73%). Finally, 147 participants (65.92%) chose to undergo IPD, and 47 cases were confirmed. The combined positive predictive value (PPV) of NIPT for SCA was 31.97% (47\/147). PPV was high for 47,XYY (100%, 11\/11), moderate for 47,XXX (42.86%, 9\/21) and 47,XXY (45.45%, 15\/33), but low for 45,X (16.13%, 10\/62) and 46,XY,del(X) (10%, 2\/20). The termination rates of Turner syndrome and 47,XXY syndrome were higher than 47,XXX and 47,XYY syndromes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this relatively large cohort, we evaluated the value of NIPT for SCAs. Our data showed that with informed consent and subsequent professional genetical consulting, NIPT can be a useful method to screen SCAs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2021.672211","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:40:44Z","timestamp":1643157644000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Application of Noninvasive Prenatal Testing for Sex Chromosome Aneuploidies in Central China"],"prefix":"10.3389","volume":"8","author":[{"given":"Ganye","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1373\/clinchem.2013.215145","article-title":"Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing","volume":"60","author":"Wang","year":"2014","journal-title":"Clin Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1469-8749.2009.03545.x","article-title":"Neurocognitive outcomes of individuals with a sex chromosome trisomy: XXX, XYY, or XXY: a systematic review","volume":"52","author":"Leggett","year":"2010","journal-title":"Dev Med Child Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/B978-0-444-63233-3.00024-5","article-title":"Sex chromosome aneuploidies","volume":"147","author":"Skuse","year":"2018","journal-title":"Handb Clin Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-4939-8889-1_3","article-title":"Noninvasive Approaches to Prenatal Diagnosis: Historical Perspective and Future Directions","volume":"1885","author":"Hui","year":"2019","journal-title":"Methods Mol Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3390\/genes12040501","article-title":"Chances and challenges of new genetic screening technologies (NIPT) in prenatal medicine from a clinical perspective: a narrative review","volume":"12","author":"Bedei","year":"2021","journal-title":"Genes (Basel)."},{"key":"B6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/14737159.2021.1911651","article-title":"Noninvasive prenatal screening for fetal sex chromosome aneuploidies","volume":"21","author":"Deng","year":"2021","journal-title":"Expert Rev Mol Diagn."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e3362","DOI":"10.1002\/jgm.3362","article-title":"An assessment of the analytical performance of non-invasive prenatal testing (NIPT) in detecting sex chromosome aneuploidies: 34,717-patient sample in a single prenatal diagnosis Centre in China","volume":"23","author":"Luo","year":"2021","journal-title":"J Gene Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.1038\/s41598-019-44018-4","article-title":"Clinical application of noninvasive prenatal screening for sex chromosome aneuploidies in 50,301 pregnancies: initial experience in a Chinese hospital","volume":"9","author":"Deng","year":"2019","journal-title":"Sci Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s10815-020-01977-2","article-title":"Next-generation sequencing: a follow-up of 36,913 singleton pregnancies with noninvasive prenatal testing in central China","volume":"37","author":"Lu","year":"2020","journal-title":"J Assist Reprod Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/pd.4002","article-title":"Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors","volume":"32","author":"Dan","year":"2012","journal-title":"Prenat Diagn."},{"key":"B11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/pd.4103","article-title":"Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y","volume":"33","author":"Nicolaides","year":"2013","journal-title":"Prenat Diagn."},{"key":"B12","doi-asserted-by":"publisher","first-page":"365 e1","DOI":"10.1016\/j.ajog.2014.03.042","article-title":"Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA","volume":"211","author":"Porreco","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/uog.14792","article-title":"Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies","volume":"45","author":"Zhang","year":"2015","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.10.005","article-title":"Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory","author":"Petersen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/pd.5328","article-title":"Perinatal outcomes following cell-free DNA screening in >32 000 women: Clinical follow-up data from a single tertiary center","volume":"38","author":"Liang","year":"2018","journal-title":"Prenat Diagn."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000501014","article-title":"Clinical Application of Cell-Free DNA Sequencing-Based Noninvasive Prenatal Testing for Trisomies 21, 18, 13 and Sex Chromosome Aneuploidy in a Mixed-Risk Population in Iran","author":"Garshasbi","year":"2019","journal-title":"Fetal Diagn Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11427-019-9600-0","article-title":"Evidence of compliance with and effectiveness of guidelines for noninvasive prenatal testing in China: a retrospective study of 189,809 cases","volume":"63","author":"Tian","year":"2020","journal-title":"Sci China Life Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/uog.20416","article-title":"Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China","volume":"55","author":"Xu","year":"2020","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10815-020-02056-2","article-title":"Noninvasive prenatal detection of fetal sex chromosome abnormalities using the semiconductor sequencing platform (SSP) in Southern China","volume":"38","author":"Yang","year":"2021","journal-title":"J Assist Reprod Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajog.2018.05.030","article-title":"Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing","volume":"219","author":"Wang","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13039-019-0464-y","article-title":"A case of prenatal diagnosis of 18p deletion syndrome following noninvasive prenatal testing","volume":"12","author":"Zhao","year":"2019","journal-title":"Mol Cytogenet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/14737159.2019.1613154","article-title":"Screening, prenatal diagnosis, and prenatal decision for sex chromosome aneuploidy","volume":"19","author":"Xu","year":"2019","journal-title":"Expert Rev Mol Diagn."},{"key":"B27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/AOG.0000000000000637","article-title":"Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology","volume":"125","author":"Bianchi","year":"2015","journal-title":"Obstet Gynecol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e69679","DOI":"10.7554\/eLife.69679","article-title":"The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma","volume":"10","author":"Yuwono","year":"2021","journal-title":"Elife."},{"key":"B29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.tjog.2014.10.009","article-title":"Maternal mosaicism of sex chromosome causes discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing","volume":"54","author":"Wang","year":"2015","journal-title":"Taiwan J Obstet Gynecol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/humrep\/deh117","article-title":"Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells","volume":"19","author":"Flori","year":"2004","journal-title":"Case report Hum Reprod."},{"key":"B31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/GCO.0000000000000610","article-title":"Predicting fetoplacental mosaicism during cfDNA-based NIPT","volume":"32","author":"Neofytou","year":"2020","journal-title":"Curr Opin Obstet Gynecol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/pd.5223","article-title":"Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing","volume":"38","author":"Brison","year":"2018","journal-title":"Prenat Diagn."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000357198","article-title":"Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysis","volume":"35","author":"Nicolaides","year":"2014","journal-title":"Fetal Diagn Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000098184","article-title":"X chromosome loss and ageing","volume":"116","author":"Russell","year":"2007","journal-title":"Cytogenet Genome Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/pd.4338","article-title":"Non-invasive risk assessment of fetal sex chromosome aneuploidy through directed analysis and incorporation of fetal fraction","volume":"34","author":"Hooks","year":"2014","journal-title":"Prenat Diagn."},{"key":"B36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/ajmg.c.31437","article-title":"Positive effects of early androgen therapy on the behavioral phenotype of boys with 47,XXY","volume":"169","author":"Samango-Sprouse","year":"2015","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.21037\/atm.2019.06.57","article-title":"Clinical features and pregnancy outcomes of women with abnormal cell-free fetal DNA test results","volume":"7","author":"Zhou","year":"2019","journal-title":"Ann Transl Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jgc4.1122","article-title":"Current genetic counseling practice in the United States following positive non-invasive prenatal testing for sex chromosome abnormalities","volume":"28","author":"Fleddermann","year":"2019","journal-title":"J Genet Couns."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.672211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:40:46Z","timestamp":1643157646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.672211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":38,"alternative-id":["10.3389\/fmed.2021.672211"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.672211","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"article-number":"672211"}}